Publication Date
2011
Journal
The Texas Heart Journal
PMID
21720462
Publication Date(s)
2011
Language
English
PMCID
PMC3113132
PubMedCentral® Posted Date
2011
PubMedCentral® Full Text Version
Post-Print
Published Open-Access
yes
Keywords
Animals, Antineoplastic Agents, Cardiology, Cooperative Behavior, Delivery of Health Care, Integrated, Heart, Heart Diseases, Humans, Interdisciplinary Communication, Medical Oncology, Myocytes, Cardiac, Patient Care Team, Prognosis, Risk Assessment, Risk Factors
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Abstract
Onco-cardiology is an evolving discipline that requires the consideration of cardiotoxicity in preclinical, clinical,and therapeutic aspects of protocol development,treatment, and surveillance of patients who have undergone interventions using cardiotoxic agents. Only then can we foster new ways to maximize survival while keeping cardiac damage within acceptable limits. It is to this end that our working together has brought us to our present understanding. In the future, we may expect onco-cardiology to play an even greater role in the care of cancer patients.